• Extractables portal
  • BioPhorum membership
  • Contact us
  • WebsiteLog in
  • Home
  • Phorums
    • Cell & Gene Therapy
    • Development Group
    • Drug Substance
    • Fill Finish
    • Information Technology
    • MedTech
    • Regulatory
    • Supply Partner
    • Sustainability
    • Technology Roadmapping
  • Industry priorities
    • Buffer stock blending system
    • Change notification
    • Closure playbook
    • Cyber security
    • Digital integration of sponsor and contract organizations
    • Digital plant maturity model
    • Extractables and leachables
    • Forecast and demand planning
    • In-Line Monitoring and Real-Time Release
    • IT for cell and gene therapies
    • Knowledge management
    • Lab of the future
    • Raw materials
    • Single-use systems
    • Sterile Filtration QRM & PUPSIT
    • Technology adoption
  • About
    • About BioPhorum
    • Deliverables Report
    • Webinars and Podcasts
    • BioPhorum publications
    • External collaborations
    • Leadership
    • BioPhorum membership
    • Work with us
    • Review for BioPhorum
    • Legals
  • BioPhorum Home
  • Phorums
    • Cell & Gene Therapy
    • Development Group
    • Drug Substance
    • Fill Finish
    • Information Technology
    • MedTech
    • Regulatory
    • Supply Partner
    • Sustainability
    • Technology Roadmapping
  • Industry priorities
    • Buffer stock blending system
    • Change Notification
    • Closure playbook
    • Cyber security
    • Digital integration of sponsor and contract organizations
    • Digital plant maturity model
    • Extractables and leachables
    • Forecast and demand planning
    • In-Line Monitoring and Real-Time Release
    • IT for cell and gene therapies
    • Knowledge Management
    • Lab of the future
    • Raw materials
    • Single-use systems
    • Sterile Filtration QRM & PUPSIT
  • BioPhorum directory
  • Extractables Portal
  • About
    • BioPhorum Deliverables report
    • Webinars and Podcasts
    • External collaborations
    • Leadership
    • External collaborations
    • Membership
    • Work with us
    • Review for BioPhorum
    • Legals
  • Contact us
Continued process verification (CPV) and the validation of informatics systems

Continued process verification (CPV) and the validation of informatics systems

by BioPhorum | Nov 21, 2018

Continued process verification (CPV) is an activity that provides ongoing verification of the performance of a manufacturing process. Guidance issued by the FDA in 2011 emphasized the importance of manufacturers engaging in CPV as an integral part of their process...
Human performance (HuP): Guide to implementing and maintaining a leader observation and coaching program

Human performance (HuP): Guide to implementing and maintaining a leader observation and coaching program

by BioPhorum | Oct 18, 2018

A critical part of establishing competence in human performance in the biopharmaceutical industry is creating a culture where leaders partner with workers to learn about what enables success and what creates challenges. This learning is most effectively done through...
Human performance (HuP): A new measurement approach to better drive, safety, quality, reliability in biopharmaceuticals

Human performance (HuP): A new measurement approach to better drive, safety, quality, reliability in biopharmaceuticals

by BioPhorum | Aug 8, 2018

This guide developed by the Human Performance (HuP) team has explains how biopharmaceutical operations can understand and measure performance in a more meaningful way to capture risks and enable sustainable learning and improvement, through what is known as the Family...
Continued process verification (CPV) of legacy products in the biopharmaceutical industry

Continued process verification (CPV) of legacy products in the biopharmaceutical industry

by BioPhorum | Jun 26, 2018

The foundational document Continued process verification (CPV): An industry position paper with an example plan published in 2014 describes how to implement CPV. This helped companies accelerate the implementation of CPV by 30% and decreased investigation times by up...
Human performance (HuP): Changing the performance paradigm in pharma/biotech: Integrating human performance in global organizations

Human performance (HuP): Changing the performance paradigm in pharma/biotech: Integrating human performance in global organizations

by BioPhorum | Sep 28, 2015

Errors are a part of life. In a pharmaceutical context, though, errors affect safety and quality and can lead to issues with supply. Direct financial impact from lost batches, investigations, and remediation activities—as well as compliance issues, higher inventory...

Follow Us

  • Facebook
  • LinkedIn
  • Twitter

Contact address

BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG

Phorums

  • Cell & Gene Therapy
  • Development Group
  • Drug Substance
  • Fill Finish
  • Information Technology
  • MedTech
  • Supply Partner
  • Sustainability
  • Technology Roadmapping
  • Regulatory

Newsletter subscribe

Enter your E-mail address to receive our monthly newsletter direct to your inbox.

This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

© 2019 BioPhorum Operations Group · All Rights Reserved
Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ
Company Number 06794795 · VAT Number GB298617544

Privacy Policy
Designed and Powered by Powerloop Ltd.

[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin